SGT-212

· Solid Biosciences Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SGT-212, covering 2026-03-09 to 2026-03-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SGT-212 Gene Therapy in Friedreich's Ataxia [Phase 1]